Annual Total Liabilities
$6.39 M
+$2.71 M+73.41%
31 December 2023
Summary:
Yield10 Bioscience annual total liabilities is currently $6.39 million, with the most recent change of +$2.71 million (+73.41%) on 31 December 2023. During the last 3 years, it has risen by +$1.40 million (+28.06%). YTEN annual total liabilities is now -88.14% below its all-time high of $53.88 million, reached on 31 December 2005.YTEN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$9.21 M
+$1.65 M+21.84%
30 June 2024
Summary:
Yield10 Bioscience quarterly total liabilities is currently $9.21 million, with the most recent change of +$1.65 million (+21.84%) on 30 June 2024. Over the past year, it has increased by +$3.56 million (+62.94%). YTEN quarterly total liabilities is now -87.72% below its all-time high of $74.96 million, reached on 30 September 2006.YTEN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +73.4% | +62.9% |
| 3 y3 years | +28.1% | +106.5% |
| 5 y5 years | -12.0% | +35.4% |
YTEN Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.4% | at high | +149.8% |
| 5 y | 5 years | -69.3% | +73.4% | -55.8% | +149.8% |
| alltime | all time | -88.1% | +89.0% | -87.7% | +282.8% |
Yield10 Bioscience Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $9.21 M(+21.8%) |
| Mar 2024 | - | $7.56 M(+18.2%) |
| Dec 2023 | $6.39 M(+73.4%) | $6.39 M(+13.1%) |
| Sept 2023 | - | $5.65 M(+6.9%) |
| June 2023 | - | $5.28 M(+26.1%) |
| Mar 2023 | - | $4.19 M(+13.7%) |
| Dec 2022 | $3.69 M(-16.0%) | $3.69 M(-9.1%) |
| Sept 2022 | - | $4.05 M(+1.2%) |
| June 2022 | - | $4.00 M(+2.8%) |
| Mar 2022 | - | $3.89 M(-11.3%) |
| Dec 2021 | $4.39 M(-12.0%) | $4.39 M(-1.5%) |
| Sept 2021 | - | $4.46 M(-6.1%) |
| June 2021 | - | $4.75 M(+6.1%) |
| Mar 2021 | - | $4.47 M(-10.3%) |
| Dec 2020 | $4.99 M(-76.0%) | $4.99 M(+4.5%) |
| Sept 2020 | - | $4.77 M(-2.2%) |
| June 2020 | - | $4.88 M(-14.7%) |
| Mar 2020 | - | $5.72 M(-72.5%) |
| Dec 2019 | $20.80 M(+186.5%) | $20.80 M(+206.0%) |
| Sept 2019 | - | $6.80 M(+1.4%) |
| June 2019 | - | $6.70 M(-2.9%) |
| Mar 2019 | - | $6.90 M(-5.0%) |
| Dec 2018 | $7.26 M(+114.9%) | $7.26 M(+158.5%) |
| Sept 2018 | - | $2.81 M(+15.6%) |
| June 2018 | - | $2.43 M(+1.0%) |
| Mar 2018 | - | $2.40 M(-28.8%) |
| Dec 2017 | $3.38 M(-22.8%) | $3.38 M(+11.8%) |
| Sept 2017 | - | $3.02 M(-21.0%) |
| June 2017 | - | $3.83 M(-2.7%) |
| Mar 2017 | - | $3.93 M(-10.2%) |
| Dec 2016 | $4.38 M(+7.9%) | $4.38 M(-11.5%) |
| Sept 2016 | - | $4.95 M(-5.7%) |
| June 2016 | - | $5.25 M(+53.2%) |
| Mar 2016 | - | $3.42 M(-15.7%) |
| Dec 2015 | $4.06 M(-6.4%) | $4.06 M(-6.5%) |
| Sept 2015 | - | $4.34 M(+9.5%) |
| June 2015 | - | $3.96 M(+18.7%) |
| Mar 2015 | - | $3.34 M(-23.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $4.34 M(-31.6%) | $4.34 M(-1.3%) |
| Sept 2014 | - | $4.40 M(-2.5%) |
| June 2014 | - | $4.51 M(+11.3%) |
| Mar 2014 | - | $4.05 M(-36.1%) |
| Dec 2013 | $6.34 M(+2.8%) | $6.34 M(+47.4%) |
| Sept 2013 | - | $4.30 M(+4.4%) |
| June 2013 | - | $4.12 M(+1.5%) |
| Mar 2013 | - | $4.06 M(-34.3%) |
| Dec 2012 | $6.17 M(-85.8%) | $6.17 M(+21.5%) |
| Sept 2012 | - | $5.08 M(+19.1%) |
| June 2012 | - | $4.26 M(+18.2%) |
| Mar 2012 | - | $3.61 M(-91.7%) |
| Dec 2011 | $43.45 M(+0.8%) | $43.45 M(-0.2%) |
| Sept 2011 | - | $43.54 M(+0.5%) |
| June 2011 | - | $43.30 M(+3.7%) |
| Mar 2011 | - | $41.75 M(-3.1%) |
| Dec 2010 | $43.09 M(+1.4%) | $43.09 M(+0.6%) |
| Sept 2010 | - | $42.83 M(+2.5%) |
| June 2010 | - | $41.77 M(+1.8%) |
| Mar 2010 | - | $41.02 M(-3.5%) |
| Dec 2009 | $42.51 M(+12.3%) | $42.51 M(+1.6%) |
| Sept 2009 | - | $41.83 M(+0.8%) |
| June 2009 | - | $41.51 M(+10.7%) |
| Mar 2009 | - | $37.50 M(-0.9%) |
| Dec 2008 | $37.85 M(+27.0%) | $37.85 M(+9.0%) |
| Sept 2008 | - | $34.73 M(+3.5%) |
| June 2008 | - | $33.56 M(+7.8%) |
| Mar 2008 | - | $31.12 M(+4.4%) |
| Dec 2007 | $29.80 M(+65.5%) | $29.80 M(+6.9%) |
| Sept 2007 | - | $27.89 M(+24.0%) |
| June 2007 | - | $22.48 M(+20.0%) |
| Mar 2007 | - | $18.74 M(+4.1%) |
| Dec 2006 | $18.01 M(-66.6%) | $18.01 M(-76.0%) |
| Sept 2006 | - | $74.96 M(+4.4%) |
| June 2006 | - | $71.80 M(+3.9%) |
| Mar 2006 | - | $69.12 M(+28.3%) |
| Dec 2005 | $53.88 M(+15.9%) | $53.88 M(+15.9%) |
| Dec 2004 | $46.48 M(+1195.5%) | $46.48 M |
| Dec 2002 | $3.59 M | - |
FAQ
- What is Yield10 Bioscience annual total liabilities?
- What is the all time high annual total liabilities for Yield10 Bioscience?
- What is Yield10 Bioscience annual total liabilities year-on-year change?
- What is Yield10 Bioscience quarterly total liabilities?
- What is the all time high quarterly total liabilities for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly total liabilities year-on-year change?
What is Yield10 Bioscience annual total liabilities?
The current annual total liabilities of YTEN is $6.39 M
What is the all time high annual total liabilities for Yield10 Bioscience?
Yield10 Bioscience all-time high annual total liabilities is $53.88 M
What is Yield10 Bioscience annual total liabilities year-on-year change?
Over the past year, YTEN annual total liabilities has changed by +$2.71 M (+73.41%)
What is Yield10 Bioscience quarterly total liabilities?
The current quarterly total liabilities of YTEN is $9.21 M
What is the all time high quarterly total liabilities for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly total liabilities is $74.96 M
What is Yield10 Bioscience quarterly total liabilities year-on-year change?
Over the past year, YTEN quarterly total liabilities has changed by +$3.56 M (+62.94%)